Crsp stock forecast 2025.

Despite a 26% rise over the last month or so, CRSP stock is still down 20% year-t0-date. A few months back we discussed that investors may get better levels to enter CRSP stock after it surged 3x ...About the Microsoft Corp. stock forecast. As of 2023 December 02, Saturday current price of MSFT stock is 374.300$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Microsoft stock price as been showing a rising tendency so we believe that similar market segments …Target values for the price of one Luminar Technologies share for Mar 2025. The weighted average target price per Luminar Technologies share in Mar 2025 is: 2.61. In Mar, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.345% volatility is expected. Pessimistic target level: 2.42.AA Stock 12 Months Forecast. $28.05. (1.12% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Alcoa in the last 3 months. The average price target is $28.05 with a high forecast of $41.00 and a low forecast of $14.00. The average price target represents a 1.12% change from the last price of $27.74.Shares of CRISPR Therapeutics ( CRSP -7.40%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ...

Discover historical prices for CRSP stock on Yahoo Finance. View daily, weekly or monthly format back to when CRISPR Therapeutics AG stock was issued.

CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030 + Portfolio 7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict …About the Apple, Inc. stock forecast. As of 2023 December 01, Friday current price of AAPL stock is 189.905$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Apple stock price as been showing a rising tendency so we believe that similar market segments were very popular …

Be the first to know when Wall Street analysts revise their CRWD stock forecasts and price targets. Get Free CRWD Updates. CRWD stock forecasts by analyst. All ... On average, 13 Wall Street analysts forecast CRWD's revenue for 2025 to be $933,992,560,162, with the lowest CRWD revenue forecast at $920,170,065,158, and the highest CRWD revenue ...The Lemonade stock prediction for 2025 is currently $ 14.81, assuming that Lemonade shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -16.16% increase in the LMND stock price. Target values for the price of one CRISPR Therapeutics share for Feb 2026. The weighted average target price per CRISPR Therapeutics share in Feb 2026 is: 39.08. In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.704% volatility is expected. Pessimistic target level: 35.58.Forecast target price for 10-29-2023: $41.07. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 2.788%. Pessimistic ...View the latest CRISPR Therapeutics AG (CRSP) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Exela Technologies, Inc. (NASDAQ:XELA) issued its quarterly earnings results on Friday, November, 5th. The company reported ($1,080.00) earnings per share for the quarter, missing the consensus estimate of ($680.00) by $400.00. The business had revenue of $279.23 million for the quarter, compared to analysts' expectations of $310 …

Nov 17, 2022 · With that in mind, let's look at two gene-editing-focused biotechs that could perform substantially better next year: CRISPR Therapeutics ( CRSP -6.39%) and Bluebird Bio ( BLUE -4.44%). These ...

Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing.Nikola Stock Forecast, NKLA stock price prediction. Price target in 14 days: 1.060 USD. ... Nikola Corp Stock Price Forecast for 2025: January 2025: Open: 0.000001 ...The CRISPR Therapeutics stock price gained 2.88% on the last trading day (Friday, 1st Dec 2023), rising from $66.73 to $68.65. During the last trading day the stock fluctuated 8.38% from a day low at $63.39 to a day high of $68.70. The price has been going up and down for this period, and there has been a 15.92% gain for the last 2 weeks.Lithium Americas stock prediction for December 2024. In the beginning at 5.79. Maximum 6.00, minimum 5.12. The averaged price 5.62. At the end of the month 5.56 dollars, change for December -4.0%. Lithium Americas stock price forecast for January 2025. In the beginning at 5.56. Maximum 6.43, minimum 5.47.Microsoft Corp Revenue Forecast for 2023 - 2025 - 2030. In the last four years, Microsoft Corp's Revenue has grown by 57.55%, rising from $125.84B to $198.27B. For next year, analysts predict Revenue of $257.87B, which would mean an increase of 30.06%. Over the next seven years, experts predict that Microsoft Corp's Revenue will …Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.

Vortex Energy Corp () Stock Market info Recommendations: Buy or sell Vertex Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Vertex Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Vertex Pharmaceuticals's VRTX shares and …The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast.TRANSAMERICA LIFEGOALSM 2025 FUND- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies StocksCRISPR Therapeutics Stock Forecast 30 Nov. Presumably, on 11/30/2023, the price of shares will be in the range of $51.94 - $53.92. A $1.98 range width can provide 3.81% volatility. The weighted average price of this range is at $53.49, which is $0.93 higher than the previous day's weighted average price.Traders Union experts conducted a comprehensive analysis and predicted that by the end of 2024 Google price will hit $179.92. Google will grow to $200.9 in 2025, $279.67 in 2028 and $348.68 in 2030. Traders Union analysts have prepared a selection of analytical forecasts from top portals for 2024, 2025, 2030.TRANSAMERICA LIFEGOALSM 2025 FUND- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies Stocks

CRISPR Therapeutics last issued its quarterly earnings data on November 6th, 2023. The reported ($1.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.63. CRISPR Therapeutics has generated ($4.47) earnings per share over the last year ( ($4.47) diluted earnings per share).Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ...

7 brokers have issued 12-month price objectives for Sangamo Therapeutics' shares. Their SGMO share price targets range from $1.00 to $10.00. On average, they expect the company's stock price to reach $4.68 in the next twelve months. This suggests a possible upside of 1,150.3% from the stock's current price. View analysts price targets …Teladoc Health Stock Forecast 11-23-2023. Forecast target price for 11-23-2023: $ 17.85. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.410%. Pessimistic target level: 17.63. Optimistic target level: 18.06.The Roku Inc - Class A stock forecast is 205.24788816489 USD for 2024 November 30, Saturday; and 1033.706 USD for 2028 November 30, Thursday with technical analysis. Roku Inc - Class A (ROKU) stock price prediction is 205.24788816489 USD.CPRX Stock 12 Months Forecast. $23.30. (81.32% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. The average price target is $23.30 with a high forecast of $27.00 and a low forecast of $15.50. The average price target represents a 81.32% change from the last price of $12.85.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Editas Medicine share forecasts, stock quote and buy / sell signals below. According to present data Editas Medicine's EDIT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Nov 30, 2023 · C3.ai Stock Forecast 2023. $27.50. In the last five quarters, C3.ai’s Price Target has risen from $25.42 to $26.09 - a 2.64% increase. Two analysts predict that C3.ai’s share price will increase in the coming year, reaching $27.50. This would represent an increase of 5.4%.

Target values for the price of one CRISPR Therapeutics share for Jan 2024. The weighted average target price per CRISPR Therapeutics share in Jan 2024 is: 63.59. In Jan, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.790% volatility is expected. Pessimistic target level: 56.98.

Sep 19, 2023 · 32.69%. Dividend Yield. N/A. More importantly, CRISPR Therapeutics' financial results should improve in the next five years. The company is on the verge of receiving approval for exa-cel, a gene ...

Target values for the price of one CRISPR Therapeutics share for Nov 2026. The weighted average target price per CRISPR Therapeutics share in Nov 2026 is: 45.09. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.682% volatility is expected. Pessimistic target level: 43.43.According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.Nov 28, 2023 · Target values for the price of one CRISPR Therapeutics share for Jan 2024. The weighted average target price per CRISPR Therapeutics share in Jan 2024 is: 63.59. In Jan, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.790% volatility is expected. Pessimistic target level: 56.98. What analysts predict: $88.13 52-week High/Low: $72 / $37.55 50/200 Day Moving Average: $45.85 / $51.4 This figure corresponds to the Average Price over the …Gene-editing therapies aren't common today, but years from now that could change. One company that hopes to be at the center of that transition is CRISPR Therapeutics ( CRSP -6.39%). The company...CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary.Stock Price Forecast According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of …Oct 15, 2020 · Roku Inc - Class A (ROKU) stock price prediction is 205.24788816489 USD. The Roku Inc - Class A stock forecast is 205.24788816489 USD for 2024 November 30, Saturday; and 1033.706 USD for 2028 November 30, Thursday with technical analysis. See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Price target in 14 days: 83.058 USD. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CRSP exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis. Markets. Stock Price Forecast The 19 analysts offering 12-month price forecasts for MercadoLibre Inc have a median target of 1,700.00, with a high estimate of 2,120.00 and a low estimate of 1,500.00.

Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations.Nokia will start 2025 at $4.39, then soar to $4.44 within the first six months of the year and finish 2025 at $4.50. That means +15% from today. Nokia Stock Forecast 2030-2034. In this period, the Nokia price would rise from $7.31 to $9.18, which is +26%.About the Alphabet, Inc. stock forecast. As of 2023 December 02, Saturday current price of GOOGL stock is 132.450$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Alphabet Inc Class A stock price as been showing a rising tendency so we believe that similar market segments …CRSP - CRISPR Therapeutics AG Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Instagram:https://instagram. enapter stockindependent contractor tax percentagecre fundmock portfolios Sep 5, 2023 · And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced 24% so far this year. And this innovative company could be at the very beginning of its ... 20 stocks of aerospace and defense companies expected to grow sales most quickly through 2025 Sep. 16, 2023 at 9:07 a.m ... projected apple stockzimmer stock About the Alphabet, Inc. stock forecast. As of 2023 December 02, Saturday current price of GOOGL stock is 132.450$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Alphabet Inc Class A stock price as been showing a rising tendency so we believe that similar market segments …And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced 24% so far this year. And this innovative company could be at the very beginning of its ... ishares sandp 500 etf Nov 14, 2023 · The share price of CRISPR Therapeutics AG (CRSP) now. What analysts predict: $88.13. 52-week High/Low: $72 / $37.55. 50/200 Day Moving Average: $45.85 / $51.4. This figure corresponds to the Average Price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the support level today. The Lemonade stock prediction for 2025 is currently $ 14.81, assuming that Lemonade shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -16.16% increase in the LMND stock price. CRISPR Therapeutics AG Stock Prediction 2025. The CRISPR Therapeutics AG stock prediction for 2025 is currently $ 114.05, assuming that CRISPR Therapeutics AG shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 70.91% increase in the CRSP stock price.